Answer
Adverse reactions attributed to Pulmozyme (dornase alfa) at the recommended dose regimen are rare (fewer than 1 in 1,000) and are usually mild and transient, without requiring dosing changes.
Sources for this answer
- Pulmozyme 2500 U/ 2.5ml, nebuliser solutionRoche Products Limited · emc · SmPC §4.8 Undesirable effects · Version 12Document updated
Sources checked